PI
RMD icon

Putnam Investments’s ResMed RMD Stock Holding History

Putnam Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$8.74M Sell
50,806
-20,975
-29% -$3.22M 0.01% 348
2023
Q3 		$10.6M Buy
71,781
+57,698
+410% +$10.4M 0.02% 300
2023
Q2 		$3.08M Buy
+14,083
New +$3.14M ﹤0.01% 626
2022
Q2 		– Sell
-25,881
Closed -$6.28M – 1204
2022
Q1 		$6.28M Sell
25,881
-8,399
-25% -$2.03M 0.01% 443
2021
Q4 		$8.93M Sell
34,280
-5,067
-13% -$1.31M 0.01% 397
2021
Q3 		$10.4M Buy
39,347
+13
+0% +$3.56K 0.02% 354
2021
Q2 		$9.7M Buy
39,334
+11,669
+42% +$2.45M 0.02% 376
2021
Q1 		$5.37M Buy
27,665
+147
+0.5% +$29.5K 0.01% 483
2020
Q4 		$5.85M Sell
27,518
-117
-0.4% -$23.3K 0.01% 472
2020
Q3 		$4.74M Sell
27,635
-43
-0.2% -$7.94K 0.01% 494
2020
Q2 		$5.31M Buy
27,678
+18,121
+190% +$2.96M 0.01% 460
2020
Q1 		$1.41M Buy
9,557
+8,192
+600% +$1.3M ﹤0.01% 680
2019
Q4 		$212K Buy
+1,365
New +$197K ﹤0.01% 870
2019
Q1 		– Sell
-92,327
Closed -$10.5M – 945
2018
Q4 		$10.5M Buy
92,327
+90,477
+4,891% +$9.69M 0.03% 312
2018
Q3 		$213K Buy
+1,850
New +$203K ﹤0.01% 1047
2016
Q2 		– Sell
-85,610
Closed -$4.95M – 1401
2016
Q1 		$4.95M Sell
85,610
-3,105
-3% -$176K 0.01% 633
2015
Q4 		$4.76M Sell
88,715
-785
-0.9% -$44.2K 0.01% 674
2015
Q3 		$4.56M Sell
89,500
-865
-1% -$46.6K 0.01% 700
2015
Q2 		$5.09M Sell
90,365
-17,100
-16% -$1.08M 0.01% 721
2015
Q1 		$7.71M Sell
107,465
-1,201
-1% -$78K 0.02% 614
2014
Q4 		$6.09M Sell
108,666
-2,040
-2% -$107K 0.01% 702
2014
Q3 		$5.46M Sell
110,706
-2,040
-2% -$104K 0.01% 736
2014
Q2 		$5.71M Sell
112,746
-2,024
-2% -$100K 0.01% 731
2014
Q1 		$5.13M Buy
114,770
+14,205
+14% +$638K 0.01% 746
2013
Q4 		$4.74M Buy
+100,565
New +$5.09M 0.01% 772

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Putnam Investments's RMD Position: Q4 2023 in Review

Putnam Investments reduced its ResMed (RMD) stake by 29% in Q4 2023, selling an estimated $3.22M and leaving 50,806 shares worth $8.74M. The position accounts for 0.01% of the portfolio, ranked #348.

Putnam Investments first reported a position in RMD in Q4 2013 and has held it in 25 quarters since. The position peaked at $10.6M in Q3 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Putnam Investments held 50,806 shares of ResMed worth $8.74M as of Q4 2023.
  • Putnam Investments sold 20,975 ResMed shares in Q4 2023, an estimated $3.22M.
  • ResMed made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #348 holding.
  • Putnam Investments first reported a position in ResMed in Q4 2013 and has held it in 25 quarters since.
  • Putnam Investments's ResMed position peaked at $10.6M in Q3 2023.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.